These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 31949814

  • 1. Serum miR-106b upregulation predicts poor prognosis in patients with colorectal cancer.
    Zhao Y, Ren Q, Zhu K.
    Int J Clin Exp Pathol; 2018; 11(8):4197-4204. PubMed ID: 31949814
    [Abstract] [Full Text] [Related]

  • 2. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G, Wang R, Wang M.
    Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
    [Abstract] [Full Text] [Related]

  • 3. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer.
    Zhang N, Zhang PP, Huang JJ, Wang ZY, Zhang ZH, Yuan JZ, Ma EM, Liu X, Bai J.
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):664-672. PubMed ID: 32016967
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer.
    Wang DS, Zhong B, Zhang MS, Gao Y.
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4518-4523. PubMed ID: 30058684
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1.
    Zhang GJ, Li JS, Zhou H, Xiao HX, Li Y, Zhou T.
    J Exp Clin Cancer Res; 2015 Jul 30; 34(1):73. PubMed ID: 26223867
    [Abstract] [Full Text] [Related]

  • 6. Upregulated serum miR-675 predicts poor prognosis for colorectal cancer.
    Zhang R, Xu J, Zhao J, Liu F.
    Int J Clin Exp Pathol; 2017 Jul 30; 10(7):8043-8049. PubMed ID: 31966656
    [Abstract] [Full Text] [Related]

  • 7. Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer.
    Tan HY, Zheng YB, Liu J.
    Eur Rev Med Pharmacol Sci; 2018 Dec 30; 22(24):8657-8663. PubMed ID: 30575906
    [Abstract] [Full Text] [Related]

  • 8. Reduced serum miR-98 predicts unfavorable clinical outcome of colorectal cancer.
    Wang YG, He Q, Guo SQ, Shi ZZ.
    Eur Rev Med Pharmacol Sci; 2019 Oct 30; 23(19):8345-8353. PubMed ID: 31646564
    [Abstract] [Full Text] [Related]

  • 9. Serum miR-133b is a potential novel prognostic biomarker for colorectal cancer.
    Yu J, Xu J, Zhao J, Zhang R.
    Int J Clin Exp Pathol; 2017 Oct 30; 10(12):11673-11678. PubMed ID: 31966526
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of serum miR-17 and miR-106b levels in gastric cancer and benign gastric diseases.
    Zeng Q, Jin C, Chen W, Xia F, Wang Q, Fan F, Du J, Guo Y, Lin C, Yang K, Li J, Peng X, Li X, Cao K.
    Chin J Cancer Res; 2014 Dec 30; 26(6):711-6. PubMed ID: 25561770
    [Abstract] [Full Text] [Related]

  • 11. The diagnostic and prognostic value of serum miR-206 in colorectal cancer.
    Liu X, Zheng W, Zhang X, Dong M, Sun G.
    Int J Clin Exp Pathol; 2017 Dec 30; 10(7):7528-7533. PubMed ID: 31966596
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of serum miR-140-5p predicts poor prognosis of patients with colorectal cancer.
    Li J, Gao J, Tian W, Li Y, Zhang J.
    Int J Clin Exp Pathol; 2017 Dec 30; 10(9):9503-9508. PubMed ID: 31966825
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of serum miR-193b in colorectal cancer.
    Xu J, Zhao J, Zhang R.
    Int J Clin Exp Pathol; 2017 Dec 30; 10(9):9509-9514. PubMed ID: 31966826
    [Abstract] [Full Text] [Related]

  • 14. Serum miR-663 expression and the diagnostic value in colorectal cancer.
    Wang N, Zeng L, Li Z, Zhen Y, Chen H.
    Artif Cells Nanomed Biotechnol; 2019 Dec 30; 47(1):2650-2653. PubMed ID: 31240955
    [Abstract] [Full Text] [Related]

  • 15. MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility.
    Zhuang M, Zhao S, Jiang Z, Wang S, Sun P, Quan J, Yan D, Wang X.
    EBioMedicine; 2019 Mar 30; 41():286-298. PubMed ID: 30797712
    [Abstract] [Full Text] [Related]

  • 16. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
    Hur K, Toiyama Y, Okugawa Y, Ide S, Imaoka H, Boland CR, Goel A.
    Gut; 2017 Apr 30; 66(4):654-665. PubMed ID: 26701878
    [Abstract] [Full Text] [Related]

  • 17. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC, Fan YS, Chen HB, Zhao DW.
    Tumour Biol; 2015 Mar 30; 36(3):1619-25. PubMed ID: 25528214
    [Abstract] [Full Text] [Related]

  • 18. The diagnostic effect of serum miR-196b as biomarker in colorectal cancer.
    Xu C, Gu L.
    Biomed Rep; 2017 Jan 30; 6(1):39-45. PubMed ID: 28123705
    [Abstract] [Full Text] [Related]

  • 19. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.
    Jiang L, Li X, Cheng Q, Zhang BH.
    Tumour Biol; 2015 Sep 30; 36(9):7167-74. PubMed ID: 25894380
    [Abstract] [Full Text] [Related]

  • 20. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L, Meng T, Yang XH, Sayim P, Lei C, Jin B, Ge L, Wang HJ.
    Cancer Biomark; 2018 Sep 30; 22(2):283-299. PubMed ID: 29630521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.